EUVIMEDEUVIMED entdecken
ÄquivalenzstudieMultizentrische StudieRandomisierte kontrollierte Studie

Randomized Trial of Very Early Medication Abortion

Karin Brandell iD, Tagrid Jar-Allah, John Reynolds-Wright iD, Helena Kopp Kallner iD, Helena Hognert, Frida Gyllenberg, Janina Kaislasuo, Anand Tamang, Heera Tuladhar, Clare Boerma, Karen Schimanski, Gillian Gibson und 10 weitere

New England Journal of Medicine · 2024

DOI: 10.1056/nejmoa2401646 ↗

Kurz gefasst

Äquivalenzstudie in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Karin Brandell und 21 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Women's and Children's Health, Division of Obstetrics and Gynecology (K.B., K.G.-D.), and the Department of Clinical Sciences …. Hauptthemen laut MEDLINE: Abortifacient Agents, Nonsteroidal, Abortifacient Agents, Steroidal, Abortion, Induced, Mifepristone. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: European Society of Contraception and Reproductive Health, Vetenskapsrådet, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalAbortion, InducedMifepristoneMisoprostolPregnancy Trimester, FirstAdultFemaleHumansPregnancyYoung AdultGestational AgeIntention to Treat AnalysisTime-to-TreatmentUltrasonography, Prenatal

Substanzen

Abortifacient Agents, NonsteroidalAbortifacient Agents, SteroidalMifepristoneMisoprostol

Autor:innen und Institutionen

  • From the Department of Women's and Children's Health, Division of Obstetrics and Gynecology (K.B., K.G.-D.), and the Department of Clinical Sciences at Danderyd Hospital (H.K.K.), Karolinska Institutet, and the Departme…

ORCID-Profile: Karin Brandell, John Reynolds-Wright, Helena Kopp Kallner

Förderung

  • European Society of Contraception and Reproductive Health
  • Vetenskapsrådet
  • Karolinska Institutet
  • European Society for Contraception and Reproductive Health
  • Nordic Federation of Societies of Obstetrics and Gynecology
  • Research funds of the Hospital system of Helsinki and Uusimaa
  • Region Stockholm
  • ALF Grant - Region Stockholm/Karolinska Institutet

Zitieren

APA

Brandell, K., Jar-Allah, T., Reynolds-Wright, J., Kopp Kallner, H., Hognert, H., Gyllenberg, F., Kaislasuo, J., Tamang, A., Tuladhar, H., Boerma, C., Schimanski, K., Gibson, G., Løkeland, M., Teleman, P., Bixo, M., Mandrup Kjaer, M., Kallfa, E., Bring, J., Heikinheimo, O., …, & VEMA (Very Early Medication Abortion) Study Group (2024). Randomized Trial of Very Early Medication Abortion. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2401646

Vancouver

Brandell K, Jar-Allah T, Reynolds-Wright J, Kopp Kallner H, Hognert H, Gyllenberg F, et al. Randomized Trial of Very Early Medication Abortion. New England Journal of Medicine. 2024. doi:10.1056/nejmoa2401646

BibTeX
@article{Brandell2024,
  author = {Brandell, Karin and Jar-Allah, Tagrid and Reynolds-Wright, John and Kopp Kallner, Helena and Hognert, Helena and Gyllenberg, Frida and Kaislasuo, Janina and Tamang, Anand and Tuladhar, Heera and Boerma, Clare and Schimanski, Karen and Gibson, Gillian and Løkeland, Mette and Teleman, Pia and Bixo, Marie and Mandrup Kjaer, Mette and Kallfa, Ervin and Bring, Johan and Heikinheimo, Oskari and Cameron, Sharon and Gemzell-Danielsson, Kristina and VEMA (Very Early Medication Abortion) Study Group, VEMA (Very Early Medication Abortion) Study Group},
  title = {Randomized Trial of Very Early Medication Abortion},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmoa2401646}
}
Kostenlos starten →